Clinical Trials
5 trialsNCT05689359 2024-03-08
Evaluation of Hydroxychloroquine to Prevent CIPN
University of Arizona
Phase 2 Withdrawn
NCT04675450 2023-06-08
NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
Conjupro Biotherapeutics, Inc.
Phase 2 Withdrawn
NCT03109301 2019-04-05
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT02215083 2017-07-12
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Phase 1 Withdrawn
NCT02168894 2016-03-08
SINF: Peripheral Neuropathy in Cancer Survivors
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn